Sign In
Buy ITRM
$0.0300
+0 (+0%)
At Close: Jun 03, 2026
4 Hot Penny Stocks to Watch With High Volume in August
04:52pm, Tuesday, 03'rd Aug 2021
Top high volume penny stocks to watch in August 2021 The post 4 Hot Penny Stocks to Watch With High Volume in August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Best Penny Stocks to Watch As July Ends? 3 For Your List
09:10am, Friday, 30'th Jul 2021
Why Investors Are Watching These 3 Penny Stocks As July Comes to an End The post Best Penny Stocks to Watch As July Ends? 3 For Your List appeared first on Penny Stocks to Buy, Picks, News and Informa
Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:25am, Thursday, 29'th Jul 2021
Iterum Therapeutics PLC (ITRM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earn
ITRM Stock Falls Over 40% Pre-Market: Why It Happened
08:13am, Monday, 26'th Jul 2021
The stock price of Iterum Therapeutics PLC (NASDAQ: ITRM) fell by over 40% pre-market. This is why it happened.
Iterum Therapeutics Stock Plunges After FDA Rejects Its Sulopenem Application
08:00am, Monday, 26'th Jul 2021
Iterum Therapeutics plc (NASDAQ: ITRM) has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval for sulopenem etzadroxil/probenecid (oral sulo
Iterum Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Oral Sulopenem
07:00am, Monday, 26'th Jul 2021
DUBLIN, Ireland and CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation
Top Penny Stocks to Buy Next Week? 3 to Watch In Summer 2021
04:57pm, Friday, 16'th Jul 2021
Penny Stocks Continue to Heat Up As Summer 2021 Rolls On; Here's 3 to Watch The post Top Penny Stocks to Buy Next Week? 3 to Watch In Summer 2021 appeared first on Penny Stocks to Buy, Picks, News and
Are These Hot Penny Stocks Worth Buying Right Now? 7 For Your List
12:10pm, Friday, 09'th Jul 2021
Looking for the best penny stocks to buy in 2021? Check these 7 out for your watchlist The post Are These Hot Penny Stocks Worth Buying Right Now?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iterum Therapeutics plc (ITRM)
05:15pm, Wednesday, 07'th Jul 2021
NEW YORK, July 7, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Iterum Therapeutics plc ("Iterum" or the "Company") (NASDAQ: ITRM). Such investors are advised
Trending Reddit Penny Stocks to Buy Now? Take a Look At These 7
05:09pm, Tuesday, 06'th Jul 2021
Which Reddit penny stocks are investors watching right now? Check these 7 out The post Trending Reddit Penny Stocks to Buy Now?
Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy
08:48am, Monday, 05'th Jul 2021
Iterum looked to be on track for a July 25 PDUFA for its first commercial drug, sulopenem. Now, the company faces uncertainty as the FDA has issued a letter seeking labeling clarification.
Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter
04:43pm, Friday, 02'nd Jul 2021
A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASDAQ:ITRM) failed to deter H.C. Wainwright & Co's bullish sentiment
Why Iterum Therapeutics Stock Is Crashing Today
11:36am, Friday, 02'nd Jul 2021
The company received disappointing news from the FDA.
ITRM Stock Price Falls Over 39% Pre-Market: Why It Happened
08:32am, Friday, 02'nd Jul 2021
The stock price of Iterum Therapeutics PLC (NASDAQ: ITRM) fell by over 39% pre-market. This is why it happened.
Iterum Therapeutics Provides Regulatory Update
06:30pm, Thursday, 01'st Jul 2021
DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation
